已收盘 01-16 16:00:00 美东时间
+0.050
+0.32%
The Chemours Company ("Chemours" or "the Company") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced
01-16 06:08
专题:2025年国际财经新闻大盘点 由于需求疲软、投入成本上升和欧洲法规收紧,美国化工企业的股价将在2025年年底出现下跌。 化工企业...
2025-12-31 21:43
加密货币反弹!BMNR多张Call单涨幅逾100%,MSTR成交活跃;收购大战升级,华纳兄弟看涨期权超8成;苹果股价小幅回调,获多张大Call单押注反弹>>
2025-12-10 11:48
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
2025-12-04 09:38
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $13.
2025-12-04 00:04
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $19 to $17.
2025-11-11 00:08
The most oversold stocks in the materials sector presents an opportunity to buy...
2025-11-07 19:01
Chemours (NYSE:CC) sees FY2025 sales of $5.700 billion-$5.800 billion vs $5.882 billion analyst estimate.
2025-11-07 06:57